BNP PARIBAS ARBITRAGE, SA

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1166588 NEW YORK, NY

Back to UTHR Full portfolio

Position in UTHR

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$31,740,401

-$5,029,102 QoQ

Shares Held

58,580

-5.5% QoQ

Ownership

0.137%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#98

of 870 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $502,986,525 across 54 Drug Manufacturers - Specialty & Generic names. UTHR ranks #6 (6.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,415,471	$101,715,746
2	NBIX	Neurocrine Biosciences Inc	260,605	$43,922,366
3	RDY	Dr Reddys Laboratories Ltd	2,649,866	$38,396,558
4	ALKS	Alkermes plc.	655,140	$34,329,336
5	LNTH	Lantheus Holdings, Inc.	300,967	$33,389,278
6	UTHR	UNITED THERAPEUTICS Corp This page	58,580	$31,740,401
7	ELAN	Elanco Animal Health Inc	1,180,709	$29,057,248
8	KNSA	Kiniksa Pharmaceuticals International, plc	437,192	$27,958,428

All Filings in UTHR

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$31,740,401	58,580	-5.5%	Shares	Defined	2026-08-13
2026-03-31	$36,769,503	62,008	+47.1%	Shares	Defined	2026-05-12
2025-12-31	$20,540,511	42,156	-39.9%	Shares	Defined	2026-02-10
2025-09-30	$29,385,363	70,097	+56.1%	Shares	Defined	2025-11-13
2025-06-30	$12,900,578	44,895	+16.7%	Shares	Defined	2025-08-14
2025-03-31	$11,856,372	38,461	+6.5%	Shares	Defined	2025-05-14
2024-12-31	$12,742,463	36,114	+5.6%	Shares	Defined	2025-02-14
2024-09-30	$12,252,703	34,192	-38.5%	Shares	Defined	2024-11-13
2024-06-30	$17,713,928	55,608	+55.3%	Shares	Defined	2024-08-13
2024-03-31	$8,225,584	35,807	-35.5%	Shares	Defined	2024-05-01
2023-12-31	$12,199,717	55,481	+90.3%	Shares	Defined	2024-02-14
2023-09-30	$6,585,465	29,156	-6.0%	Shares	Defined	2023-11-14
2023-06-30	$6,846,782	31,016	-6.7%	Shares	Defined	2023-08-09
2023-03-31	$7,447,565	33,254	-37.0%	Shares	Defined	2023-05-12
2022-12-31	$14,676,477	52,776	+205.7%	Shares	Defined	2023-02-14
2022-09-30	$3,615,155	17,266	+6.9%	Shares	Defined	2022-11-16
2022-06-30	$3,805,586	16,150	-0.1%	Shares	Defined	2022-08-12
2022-03-31	$2,901,239	16,171	-55.2%	Shares	Defined	2022-05-18
2021-12-31	$7,801,352	36,104	+21.4%	Shares	Defined	2022-02-09
2021-09-30	$5,488,301	29,734	-37.1%	Shares	Defined	2021-11-16
2021-06-30	$8,479,275	47,262	+221.6%	Shares	Defined	2021-08-10
2021-03-31	$2,457,865	14,694	-82.1%	Shares	Defined	2021-05-07
2020-12-31	$12,488,674	82,276	+656.9%	Shares	Defined	2021-02-10
2020-09-30	$1,097,870	10,870	-83.7%	Shares	Defined	2020-10-30
2020-06-30	$8,093,690	66,890	+127.4%	Shares	Defined	2020-08-06
2020-03-31	$2,789,803	29,419	—	Shares	Defined	2020-05-13
No filing history on record for this holder in this stock.